Northwestern Mutual Wealth Management CO Summit Therapeutics Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $121 Billion
- Q1 2025
A detailed history of Northwestern Mutual Wealth Management CO transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 47 shares of SMMT stock, worth $931. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47Holding current value
$931% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
236Shares Held
86.8MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$484 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$231 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$157 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$130 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$96.2 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.99B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...